Drug treatment of lipid disorders

[1] ABRAMOWICZ M, 1998, MED LETT, V40, P117

[2] ABRAMOWICZ M, 1996, MED LETT, V38, P67

[3] REDUCTION OF LECITHIN-CHOLESTEROL ACYLTRANSFERASE, APOLIPOPROTEIN D AND THE LP(A) LIPOPROTEIN WITH THE ANABOLIC-STEROID STANOZOLOL [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1984, 795 (02) : 293 - 296

[4] INFLUENCE OF NICOTINIC ACID ON SERUM CHOLESTEROL IN MAN [J]. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1955, 54 (02) : 558 - 559

[5] *AM DIAB ASS, 1999, DIABETES CARE S1, V22, pS56

[6] [Anonymous], 1975, JAMA-J AM MED ASSOC, V231, P360

[7] [Anonymous], 1993, Am J Cardiol, V72, P1031

[8] [Anonymous], 1993, Arch Intern Med, V153, P1321

[9] EFFECTS OF LOVASTATIN THERAPY ON VERY-LOW-DENSITY LIPOPROTEIN TRIGLYCERIDE-METABOLISM IN SUBJECTS WITH COMBINED HYPERLIPIDEMIA - EVIDENCE FOR REDUCED ASSEMBLY AND SECRETION OF TRIGLYCERIDE-RICH LIPOPROTEINS [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 1992, 41 (05): : 487 - 493

[10] ARAD Y, 1990, J LIPID RES, V31, P567

[1] ABRAMOWICZ M, 1998, MED LETT, V40, P117

[2] ABRAMOWICZ M, 1996, MED LETT, V38, P67

[3] REDUCTION OF LECITHIN-CHOLESTEROL ACYLTRANSFERASE, APOLIPOPROTEIN D AND THE LP(A) LIPOPROTEIN WITH THE ANABOLIC-STEROID STANOZOLOL [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1984, 795 (02) : 293 - 296

[4] INFLUENCE OF NICOTINIC ACID ON SERUM CHOLESTEROL IN MAN [J]. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1955, 54 (02) : 558 - 559

[5] *AM DIAB ASS, 1999, DIABETES CARE S1, V22, pS56

[6] [Anonymous], 1975, JAMA-J AM MED ASSOC, V231, P360

[7] [Anonymous], 1993, Am J Cardiol, V72, P1031

[8] [Anonymous], 1993, Arch Intern Med, V153, P1321

[9] EFFECTS OF LOVASTATIN THERAPY ON VERY-LOW-DENSITY LIPOPROTEIN TRIGLYCERIDE-METABOLISM IN SUBJECTS WITH COMBINED HYPERLIPIDEMIA - EVIDENCE FOR REDUCED ASSEMBLY AND SECRETION OF TRIGLYCERIDE-RICH LIPOPROTEINS [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 1992, 41 (05): : 487 - 493

[10] ARAD Y, 1990, J LIPID RES, V31, P567